February 28, 2023
A single oral dose of a common antibiotic significantly decreased the risk of sepsis or death among women who had planned a vaginal birth. The findings point to a low-cost approach to reduce maternal infections and deaths in developing countries.
Lowering the risk of mother’s sepsis or death after childbirth
February 28, 2023
Osteopontin, a protein produced by certain immune cells, may aid the formation of the amyloid beta plaques that characterize Alzheimer’s disease. Mice lacking the protein had a substantial reduction in these plaques and improvements in cognition. Blocking osteopontin in the brain may be a potential strategy for the treatment of Alzheimer’s disease.
February 28, 2023
A team led by Purdue University’s Bruce Applegate has developed a new time-saving assay to detect an especially severe strain of E. coli in ground beef. The toxin produced by E. coli accounts for 175,000 illnesses annually in the United States. The U.S. Department of Agriculture’s Food Safety and Inspection Service has maintained zero tolerance for O157:H7, an E. coli strain that can be life-threatening, since 1994. Zero tolerance means that if even one cell of E. coli is detected in a standard 325-gram (11.4-ounce) sample of ground beef, the entire batch is flagged as unfit for consumption.
February 27, 2023
Eliminating animal milk alone from the diet of adults with eosinophilic esophagitis, or EoE, is as effective at treating the disease as eliminating animal milk plus five other common foods, a clinical trial funded by the National Institutes of Health has found. For people with EoE whose disease remains active after they forgo animal milk, a more restrictive diet may help them achieve remission, according to the researchers. These findings were published today in the journal The Lancet Gastroenterology & Hepatology.
Forgoing One Food Treats Eosinophilic Esophagitis as Well as Excluding Six
February 21, 2023
Detecting the earliest signs of Alzheimer’s disease (AD) in middle-aged people and tracking its progression over time in research studies continue to be challenging. But it is easier to do in shorter-lived mammalian models of AD, especially when paired with cutting-edge imaging tools that look across different regions of the brain. These tools can help basic researchers detect telltale early changes that might point the way to better prevention or treatment strategies in humans.
February 20, 2023
Purdue University College of Health and Human Sciences researchers Heather Eicher-Miller, associate professor in the Department of Nutrition Science, and Libby Richards, associate professor in the School of Nursing, published findings from cluster analyses on temporal nutrition intake as well as when and how hard to exercise in a 24-hour span.
Purdue News: PURDUE HHS RESEARCHERS ANALYZE BEST TIMES TO EAT, EXERCISE IN A DAY
February 17, 2023
Professor Low, Purdue University’s Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry, helped develop Cytalux, a fluorescent marker that allows cancer surgeons to quickly identify malignant cells and remove them during surgery. The Food and Drug Administration approved the drug in November 2021 for ovarian cancer, and in December 2022, the FDA approved Cytalux to help doctors during lung cancer surgery as well.
Purdue News: FDA Authorizes Lung Cancer Imaging Agent Based on Research From Purdue
February 16, 2023
Since the start of the COVID-19 pandemic, many people with cancer have had telehealth visits with their doctors. Compared with in-person visits, telehealth may save people with cancer time, travel, and money, a new study suggests.
Telehealth Can Save People with Cancer Time, Travel, and Money
February 16, 2023
Black and Hispanic Americans appear to experience more symptoms and health problems related to long COVID(link is external), a lay term that captures an array of symptoms and health problems, than white people, but are not as likely to be diagnosed with the condition, according to new research funded by the National Institutes of Health. The findings – from two different studies by NIH’s Researching COVID to Enhance Recovery(link is external) (RECOVER) Initiative – add to a growing body of research aimed to better understand the complex symptoms and other issues associated with long COVID that millions have experienced.
NIH RECOVER research identifies potential long COVID disparities
February 16, 2023
Research teams led by faculty at both Indiana University School of Medicine and the Purdue University College of Engineering were recently awarded pilot grants to fund joint research projects as part of a growing ecosystem of collaboration and integration between the two schools and to continue to build momentum for the planned institute for Engineering in Medicine.
Purdue News: IU, Purdue research teams awarded pilot funding through Engineering in Medicine collaboration
